Edoardo Lenci

Publication Activity (10 Years)

Years Active: 2021-2021
Publications (10 Years): 3

Top Topics

Cross Sectional

Advanced Non Small Cell Lung Cancer

Epidermal Growth Factor Receptor

Top Venues

Exploration of targeted anti-tumor therapy

Journal of clinical medicine

This page only lists publications with an associated author ORCID identifier.

Publications

Elena Maccaroni, Edoardo Lenci, Veronica Agostinelli, Valeria Cognigni, Riccardo Giampieri, Paola Mazzanti, Marzia Di Pietro Paolo, Francesca Bianchi, Cristiana Brugiati, Laura Belvederesi, Silvia Pagliaretta, Alessandra Mandolesi, Marina Scarpelli, Alberto Murrone, Francesca Morgese, Zelmira Ballatore, Rossana Berardi
Lynch syndrome-associated lung cancer: pitfalls of an immunotherapy-based treatment strategy in an unusual tumor type. Exploration of targeted anti-tumor therapy 2 (3) (2021)
Edoardo Lenci, Luca Cantini, Federica Pecci, Valeria Cognigni, Veronica Agostinelli, Giulia Mentrasti, Alessio Lupi, Nicoletta Ranallo, Francesco Paoloni, Silvia Rinaldi, Linda Nicolardi, Andrea Caglio, Sophie Aerts, Alessio Cortellini, Corrado Ficorella, Rita Chiari, Massimo Di Maio, Anne-Marie C Dingemans, Joachim G J V Aerts, Rossana Berardi
The Gustave Roussy Immune (GRIm)-Score Variation Is an Early-on-Treatment Biomarker of Outcome in Advanced Non-Small Cell Lung Cancer (NSCLC) Patients Treated with First-Line Pembrolizumab. Journal of clinical medicine 10 (5) (2021)
Edoardo Lenci, Giulia Marcantognini, Valeria Cognigni, Alessio Lupi, Silvia Rinaldi, Luca Cantini, Ilaria Fiordoliva, Anna Lisa Carloni, Marco Rocchi, Lina Zuccatosta, Stefano Gasparini, Rossana Berardi
Tumor burden as possible biomarker of outcome in advanced NSCLC patients treated with immunotherapy: a single center, retrospective, real-world analysis. Exploration of targeted anti-tumor therapy 2 (3) (2021)